Erika joined the Harvard University Office of Technology Development in 2018. She works closely with the faculty, staff, and business teams at the Wyss Institute to commercialize their ideas and inventions through strategic partnerships. Erika was previously the Director of Product Planning and Strategy at Sofregen Medical Inc., a Tufts University spin-out developing injectable products for soft tissue augmentation. Her role included clinical trial design, regulatory and intellectual property strategy, marketing, and business development activities. Prior to joining Sofregen Medical, she held licensing roles at both Partners Innovation and Tufts Tech Transfer managing complex academic portfolios in materials science, engineering, imaging, and software. Erika earned a doctorate in Biological Chemistry from Wake Forest University and completed her postdoctoral work under the guidance of Jacquin Niles in the Biological Engineering Department at the Massachusetts Institute of Technology.